National Association of Testing Authorities, Australia
Scope of Accreditation
The Queen Elizabeth Hospital
Site
Division of Medicine – Clinical Pharmacology Laboratory
Accreditation No.
3095
Site No.
3088
Date of Accreditation
27 Feb 1991
Address
The Queen Elizabeth Hospital, Basil Hetzel Institute, 37A Woodville Road
Woodville, SA 5011
Australia
Contact
Availability
Services available to external clients
Supervision
S (Specialised)
Scope of Accreditation
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
06 Apr 2027
Last Activity Date
19 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Everolimus; Sirolimus; Tacrolimus |
| Plasma | Erlotinib; Gefitinib; Imatinib; N-desethyl Sunitinib; Pazopanib; Sunitinib | |
| Lamotrigine; Mycophenolate | ||
| Hydroxyperhexiline (OH-perhexiline); Perhexiline |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3095
Site No.
3088
Print date
27 Jul 2024
